Posted by Michael Wonder on 15 Aug 2019
US politicians round on generics firms for blocking drug pricing probe
15 August 2019 - Renews focus on increases in generic drug prices.
US politicians are going after Heritage Pharmaceuticals, Mylan and Teva Pharmaceutical Industries for allegedly stonewalling an earlier effort to gather drug pricing information.
The back and forth between the three generic drug manufacturers and the politicians, one of whom is potential presidential candidate Bernie Sanders, dates back to a request for information in 2014.
